NCT02106975View on ClinicalTrials.gov

Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 16, 2017

Study Completion Date

January 8, 2018

Conditions
Acute Lung InjurySepsis
Interventions
DRUG

Ascorbic Acid

Intervention

DRUG

Placebo: 5% Dextrose in water

Placebo

Trial Locations (5)

23298

Virginia Commonwealth University Health System, Richmond

30322

Emory University and Grady Memorial Hospital, Atlanta

40506

University of Kentucky, Lexington

44106

The Cleveland Clinic, Cleveland

53226

Froedtert and The Medical College of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Virginia Commonwealth University

OTHER

NCT02106975 - Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury | Biotech Hunter | Biotech Hunter